已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

医学 危险系数 安慰剂 冲程(发动机) 心肌梗塞 不利影响 他汀类 临床终点 入射(几何) 随机化 内科学 胃肠病学 随机对照试验 置信区间 心脏病学 外科 病理 替代医学 工程类 物理 光学 机械工程
作者
Steven E. Nissen,A. Michael Lincoff,Danielle M. Brennan,Kausik K. Ray,Denise Mason,John J.P. Kastelein,Paul D. Thompson,Peter Libby,Leslie Cho,Jorge Plutzky,Harold Bays,Patrick M. Moriarty,Venu Menon,Diederick E. Grobbee,Michael J. Louie,Chien‐Feng Chen,Na Li,LeAnne T. Bloedon,Paula Robinson,Maggie Horner,William J. Sasiela,James McCluskey,Deborah Davey,Pedro Fajardo-Campos,Predrag Petrović,Ján Fedačko,Witold Żmuda,Yury Lukyanov,Stephen J. Nicholls
出处
期刊:The New England Journal of Medicine [New England Journal of Medicine]
卷期号:388 (15): 1353-1364 被引量:403
标识
DOI:10.1056/nejmoa2215024
摘要

Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on cardiovascular outcomes remain uncertain.We conducted a double-blind, randomized, placebo-controlled trial involving patients who were unable or unwilling to take statins owing to unacceptable adverse effects ("statin-intolerant" patients) and had, or were at high risk for, cardiovascular disease. The patients were assigned to receive oral bempedoic acid, 180 mg daily, or placebo. The primary end point was a four-component composite of major adverse cardiovascular events, defined as death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization.A total of 13,970 patients underwent randomization; 6992 were assigned to the bempedoic acid group and 6978 to the placebo group. The median duration of follow-up was 40.6 months. The mean LDL cholesterol level at baseline was 139.0 mg per deciliter in both groups, and after 6 months, the reduction in the level was greater with bempedoic acid than with placebo by 29.2 mg per deciliter; the observed difference in the percent reductions was 21.1 percentage points in favor of bempedoic acid. The incidence of a primary end-point event was significantly lower with bempedoic acid than with placebo (819 patients [11.7%] vs. 927 [13.3%]; hazard ratio, 0.87; 95% confidence interval [CI], 0.79 to 0.96; P = 0.004), as were the incidences of a composite of death from cardiovascular causes, nonfatal stroke, or nonfatal myocardial infarction (575 [8.2%] vs. 663 [9.5%]; hazard ratio, 0.85; 95% CI, 0.76 to 0.96; P = 0.006); fatal or nonfatal myocardial infarction (261 [3.7%] vs. 334 [4.8%]; hazard ratio, 0.77; 95% CI, 0.66 to 0.91; P = 0.002); and coronary revascularization (435 [6.2%] vs. 529 [7.6%]; hazard ratio, 0.81; 95% CI, 0.72 to 0.92; P = 0.001). Bempedoic acid had no significant effects on fatal or nonfatal stroke, death from cardiovascular causes, and death from any cause. The incidences of gout and cholelithiasis were higher with bempedoic acid than with placebo (3.1% vs. 2.1% and 2.2% vs. 1.2%, respectively), as were the incidences of small increases in serum creatinine, uric acid, and hepatic-enzyme levels.Among statin-intolerant patients, treatment with bempedoic acid was associated with a lower risk of major adverse cardiovascular events (death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization). (Funded by Esperion Therapeutics; CLEAR Outcomes ClinicalTrials.gov number, NCT02993406.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小叶完成签到 ,获得积分10
刚刚
小佛爷完成签到 ,获得积分10
刚刚
leeb完成签到,获得积分10
1秒前
晨曦完成签到,获得积分0
2秒前
小枣完成签到 ,获得积分10
10秒前
小猪啵比完成签到 ,获得积分20
14秒前
15秒前
穆紫发布了新的文献求助10
21秒前
25秒前
史前巨怪完成签到,获得积分10
27秒前
庄默羽发布了新的文献求助10
30秒前
sandra完成签到 ,获得积分10
30秒前
x跳完成签到,获得积分10
34秒前
白蓝完成签到 ,获得积分10
36秒前
40秒前
40秒前
42秒前
哈哈Hank发布了新的文献求助10
47秒前
庄默羽发布了新的文献求助10
47秒前
48秒前
斐然诗完成签到 ,获得积分10
51秒前
ZJ完成签到,获得积分10
51秒前
bkagyin应助哈哈嘻嘻采纳,获得10
52秒前
嗯嗯嗯完成签到 ,获得积分20
52秒前
rid4iuclous2完成签到 ,获得积分10
55秒前
科研狗发布了新的文献求助20
55秒前
莫名乐乐完成签到,获得积分10
57秒前
Jackylee完成签到,获得积分10
58秒前
斯文败类应助TTT0530采纳,获得10
58秒前
1111完成签到 ,获得积分10
58秒前
允胖胖完成签到 ,获得积分10
59秒前
1111关注了科研通微信公众号
1分钟前
1分钟前
楼醉山完成签到,获得积分10
1分钟前
科研通AI2S应助郜雨寒采纳,获得10
1分钟前
庄默羽发布了新的文献求助10
1分钟前
李加一完成签到 ,获得积分10
1分钟前
情怀应助sjxx采纳,获得10
1分钟前
1分钟前
nadia完成签到,获得积分10
1分钟前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139400
求助须知:如何正确求助?哪些是违规求助? 2790323
关于积分的说明 7794903
捐赠科研通 2446762
什么是DOI,文献DOI怎么找? 1301366
科研通“疑难数据库(出版商)”最低求助积分说明 626153
版权声明 601141